(Q41060502)

26 September 2017

1 reference

title

Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability (English)

1 reference

26 September 2017

1 reference

2

A Markham

0 references

author name string

R Davis

series ordinal

1

1 reference

26 September 2017

A Markham

series ordinal

2

1 reference

26 September 2017

J A Balfour

series ordinal

3

1 reference

26 September 2017

publication date

1 June 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

51

1 reference

26 September 2017

issue

6

1 reference

26 September 2017

page(s)

1019-1074

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651060-00010

26 September 2017

exact match

0 references

cites work

Role of quinolones in the treatment of diarrhoeal diseases

1 reference

12 December 2020

Co-administration of ciprofloxacin and cyclosporin: lack of evidence for a pharmacokinetic interaction

1 reference

12 December 2020

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

1 reference

12 December 2020

E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens

1 reference

12 December 2020

Antimicrobial resistance of Shigella isolates causing traveler's diarrhea

1 reference

12 December 2020

Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations

1 reference

12 December 2020

Short course ciprofloxacin therapy for CAPD peritonitis

1 reference

12 December 2020

Management of urinary tract infections in adults

1 reference

12 December 2020

A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD)

1 reference

12 December 2020

Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure

1 reference

12 December 2020

Interference of dairy products with the absorption of ciprofloxacin

1 reference

12 December 2020

In vitro susceptibility of Salmonella to ciprofloxacin and pefloxacin compared with three other antibiotics.

1 reference

12 December 2020

Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections

1 reference

12 December 2020

Quinolones in Salmonella typhi infection

1 reference

12 December 2020

From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994

1 reference

12 December 2020

The in-vitro activity of a new highly active quinolone, DU-6859a

1 reference

12 December 2020

Treatment of nongonococcal urethritis with ciprofloxacin

1 reference

12 December 2020

Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin

1 reference

12 December 2020

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

1 reference

12 December 2020

Clinical and chemical interactions between iron preparations and ciprofloxacin

1 reference

12 December 2020

Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in Europe

1 reference

12 December 2020

Oral ciprofloxacin for osteomyelitis.

1 reference

12 December 2020

Ciprofloxacin and CAPD peritonitis

1 reference

12 December 2020

Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test

1 reference

12 December 2020

Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections

1 reference

12 December 2020

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

1 reference

12 December 2020

Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial

1 reference

12 December 2020

Does ciprofloxacin interact with cyclosporine?

1 reference

12 December 2020

Drug-drug interactions with ciprofloxacin and other fluoroquinolones

1 reference

12 December 2020

Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery

1 reference

12 December 2020

Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin

1 reference

12 December 2020

Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.

1 reference

12 December 2020

A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis

1 reference

12 December 2020

Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci

1 reference

12 December 2020

Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia

1 reference

12 December 2020

Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults

1 reference

12 December 2020

Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Sur

1 reference

12 December 2020

Intravitreal penetration of oral ciprofloxacin in humans

1 reference

12 December 2020

Respiratory tract penetration of ciprofloxacin

1 reference

12 December 2020

Ciprofloxacin in patients with bacteremic infections. The Spanish Group for the Study of Ciprofloxacin.

1 reference

12 December 2020

Antibiotic prophylaxis of travellers' diarrhoea

1 reference

12 December 2020

Concentration of ofloxacin and ciprofloxacin in human semen following a single oral dose.

1 reference

12 December 2020

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

12 December 2020

Meropenem: a microbiological overview

1 reference

12 December 2020

A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections

1 reference

12 December 2020

The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone

1 reference

12 December 2020

Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers

1 reference

12 December 2020

Management of institutional outbreaks of Salmonella gastroenteritis.

1 reference

12 December 2020

Effect of staggered dose of calcium on the bioavailability of ciprofloxacin

1 reference

12 December 2020

Extravascular penetration of ciprofloxacin. A review

1 reference

12 December 2020

Quinolone mode of action

1 reference

12 December 2020

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.

1 reference

12 December 2020

Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever

1 reference

12 December 2020

Value of single-dose ciprofloxacin in the treatment of acute uncomplicated urinary tract infection in women

1 reference

12 December 2020

Multiply antibiotic-resistant Staphylococcus epidermidis in patients, staff and environment--a one-week survey in a bone marrow transplant unit

1 reference

12 December 2020

Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth

1 reference

12 December 2020

Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea

1 reference

12 December 2020

Antimicrobial susceptibility and serotyping of Chlamydia trachomatis strains isolated before and after treatment with ciprofloxacin and doxycycline

1 reference

12 December 2020

Safety and tolerability of fluoroquinolones.

1 reference

12 December 2020

Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.

1 reference

12 December 2020

In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa

1 reference

12 December 2020

Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

In-vitro activity of ten antimicrobial agents against penicillin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Azithromycin resistance in Campylobacter jejuni and Campylobacter coli.

1 reference

12 December 2020

In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.

1 reference

12 December 2020

Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa

1 reference

12 December 2020

Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.

1 reference

12 December 2020

Effects of Temafloxacin and Ciprofloxacin on the Pharmacokinetics of Caffeine†

1 reference

12 December 2020

The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.

1 reference

12 December 2020

A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects

1 reference

12 December 2020

Chemotherapy for chronic bronchitis. Controversies.

1 reference

12 December 2020

Clinical pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

12 December 2020

Effect of a fat- and calcium-rich breakfast on pharmacokinetics of fleroxacin administered in single and multiple doses

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone

1 reference

12 December 2020

Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.

1 reference

12 December 2020

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

12 December 2020

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

1 reference

12 December 2020

Absorption interactions with fluoroquinolones. 1995 update

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Prospective randomized study comparing the efficacy and safety of ciprofloxacin with cefaclor in the treatment of patients with purulent bronchitis

1 reference

12 December 2020

Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects

1 reference

12 December 2020

Activity of four fluoroquinolones against 346 strains of enteric pathogens

1 reference

12 December 2020

Iron supplements: a common cause of drug interactions

1 reference

12 December 2020

A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections

1 reference

12 December 2020

Current approach to the treatment of travellers' diarrhoea.

1 reference

12 December 2020

Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Report of a working party of the British Society for Antimicrobial Chemotherapy

1 reference

12 December 2020

Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus

1 reference

12 December 2020

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin

1 reference

12 December 2020

Detection of ciprofloxacin resistance in gram-negative bacteria due to alterations in gyrA

1 reference

12 December 2020

Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study

1 reference

12 December 2020

Susceptibility of clinical bacterial isolates to ciprofloxacin in the United States.

1 reference

12 December 2020

Absorption of ciprofloxacin in febrile and afebrile patients.

1 reference

12 December 2020

Use of quinolones for the treatment of acute exacerbations of chronic bronchitis

1 reference

12 December 2020

4-Quinolone resistant staphylococci.

1 reference

12 December 2020

Adverse Reaction Reporting of Interaction Between Warfarin and Fluoroquinolones

1 reference

12 December 2020

Ciprofloxacin treatment of malignant external otitis

1 reference

12 December 2020

Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis

1 reference

12 December 2020

In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.

1 reference

12 December 2020

Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.

1 reference

12 December 2020

Ciprofloxacin and loperamide in the treatment of bacillary dysentery

1 reference

12 December 2020

In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study.

1 reference

12 December 2020

Analysis of the antibiotic resistance detected in 2043 strains of Salmonella enterica subsp. enterica isolated in stool cultures of Spanish patients with acute diarrhoea (1986-1991).

1 reference

12 December 2020

Effect of coadministration of a nutritional supplement on ciprofloxacin absorption

1 reference

12 December 2020

Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy

1 reference

12 December 2020

Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections

1 reference

12 December 2020

Large scale use of ciprofloxacin in the control of a Salmonella outbreak in a hospital for the mentally handicapped.

1 reference

12 December 2020

Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections

1 reference

12 December 2020

Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella.

1 reference

12 December 2020

Ciprofloxacin treatment of Staphylococcus aureus infections.

1 reference

12 December 2020

Economic impact of streamlining antibiotic administration

1 reference

12 December 2020

Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States

1 reference

12 December 2020

In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.

1 reference

12 December 2020

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates

1 reference

12 December 2020

Fluoroquinolones in the treatment of cystic fibrosis

1 reference

12 December 2020

Lower respiratory tract infection therapy--the role of ciprofloxacin

1 reference

12 December 2020

Mechanisms of quinolone resistance

1 reference

12 December 2020

Treatment of chronic osteomyelitis with ciprofloxacin

1 reference

12 December 2020

Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary.

1 reference

12 December 2020

Safety and efficacy of ciprofloxacin in paediatric patients--review

1 reference

12 December 2020

Evaluation of ciprofloxacin's activity against recent clinical isolates

1 reference

12 December 2020

Safety of ciprofloxacin. A review.

1 reference

12 December 2020

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

1 reference

12 December 2020

Empiric antibiotic therapy for acute infective diarrhoea in the developed world

1 reference

12 December 2020

Use of ciprofloxacin to control a Salmonella outbreak in a long-stay psychiatric hospital

1 reference

12 December 2020

Ciprofloxacin versus gentamicin/clindamycin for postpartum endometritis

1 reference

12 December 2020

Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy

1 reference

12 December 2020

Criteria-based antimicrobial i.v. to oral conversion program

1 reference

12 December 2020

Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.

1 reference

12 December 2020

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

12 December 2020

Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin

1 reference

12 December 2020

Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour

1 reference

12 December 2020

A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Possible interaction of ciprofloxacin with ferrous sulphate

1 reference

12 December 2020

The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin

1 reference

12 December 2020

Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis

1 reference

12 December 2020

In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents

1 reference

12 December 2020

A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis

1 reference

12 December 2020

Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.

1 reference

12 December 2020

A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients

1 reference

12 December 2020

Ciprofloxacin in the treatment of malignant external otitis

1 reference

12 December 2020

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

1 reference

12 December 2020

Modern treatment of typhoid fever

1 reference

12 December 2020

Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.

1 reference

12 December 2020

Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study

1 reference

12 December 2020

In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds.

1 reference

12 December 2020

Combined use of ciprofloxacin and sucralfate

1 reference

12 December 2020

Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin

1 reference

12 December 2020

Treatment of sepsis in patients with neoplastic diseases with intravenous ciprofloxacin

1 reference

12 December 2020

Temafloxacin: in vitro comparison with five other antibacterial agents

1 reference

12 December 2020

Prevention of infection in the neutropenic patient

1 reference

12 December 2020

Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera

1 reference

12 December 2020

Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients

1 reference

12 December 2020

Review of qoinolones in the treatment of infections of the skin and skin structure

1 reference

12 December 2020

Aging and the response to inhibition and induction of theophylline metabolism

1 reference

12 December 2020

Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections

1 reference

12 December 2020

Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever

1 reference

12 December 2020

In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistantStaphylococcus aureus andStaphylococcus epidermidis

1 reference

12 December 2020

Economic impact of oral ciprofloxacin following standard intravenous therapy

1 reference

12 December 2020

Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin

1 reference

12 December 2020

The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.

1 reference

12 December 2020

Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993

1 reference

12 December 2020

Efficacy and tolerability of norfloxacin vs. ciprofloxacin in complicated urinary tract infection.

1 reference

12 December 2020

Pharmacoeconomics of intravenous drug administration

1 reference

12 December 2020

Tolerability of fluoroquinolone antibiotics. Past, present and future

1 reference

12 December 2020

Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study.

1 reference

12 December 2020

In vitro activity of CP-74667 compared with four other fluoroquinolones

1 reference

12 December 2020

Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

1 reference

12 December 2020

Efficacy of perioperative prophylaxis with ciprofloxacin or cefazolin in colorectal surgery

1 reference

12 December 2020

Safety of oral ciprofloxacin. An update based on clinical trial results

1 reference

12 December 2020

Biliary tract infections treated with ciprofloxacin.

1 reference

12 December 2020

Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens

1 reference

12 December 2020

Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin

1 reference

12 December 2020

In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa

1 reference

12 December 2020

Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin

1 reference

12 December 2020

Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin

1 reference

12 December 2020

Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis

1 reference

12 December 2020

Single-dose preoperative prophylaxis in transurethral surgery. Ciprofloxacin versus cefotaxime

1 reference

12 December 2020

Emergence of resistance to erythromycin and fluoroquinolones in thermotolerantCampylobacter strains isolated from feces 1987–1991

1 reference

12 December 2020

Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center

1 reference

12 December 2020

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

1 reference

12 December 2020

The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.

1 reference

12 December 2020

In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes

1 reference

12 December 2020

Impermeability to quinolones in gram-positive and gram-negative bacteria

1 reference

12 December 2020

In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast

1 reference

12 December 2020

Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males.

1 reference

12 December 2020

Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital

1 reference

12 December 2020

Decreased ciprofloxacin absorption with concomitant administration of ferrous fumarate

1 reference

12 December 2020

Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.

1 reference

12 December 2020

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

12 December 2020

Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.

1 reference

12 December 2020

Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD).

1 reference

12 December 2020

Absorption of ciprofloxacin in patients with diabetic gastroparesis

1 reference

12 December 2020

Cations in the didanosine tablet reduce ciprofloxacin bioavailability.

1 reference

12 December 2020

Incomplete cross-resistance between ciprofloxacin and sparfloxacin in staphylococci, with a note on selection pressure due to clinical use of ciprofloxacin.

1 reference

12 December 2020

A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients

1 reference

12 December 2020

The in-vitro activity of biapanem against 964 clinical isolates of aerobic bacteria

1 reference

12 December 2020

Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece

1 reference

12 December 2020

Increasing resistance of Staphylococcus aureus to ciprofloxacin

1 reference

12 December 2020

Colonization by Staphylococcus species resistant to methicillin or quinolone on hands of medical personnel in a skilled-nursing facility

1 reference

12 December 2020

Activity of quinolones against mycobacteria

1 reference

12 December 2020

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches

1 reference

12 December 2020

Cost comparison of ciprofloxacin versus cefamandole

1 reference

12 December 2020

Use of the new quinolones in pediatrics.

1 reference

12 December 2020

Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.

1 reference

12 December 2020

Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use

1 reference

12 December 2020

Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid

1 reference

12 December 2020

Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.

1 reference

12 December 2020

Safety of ciprofloxacin based on phase IV studies ("Anwendungsbeobachtung") in the Federal Republic of Germany

1 reference

12 December 2020

Oral ciprofloxacin for treatment of chronic osteomyelitis

1 reference

12 December 2020

Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial

1 reference

12 December 2020

Ciprofloxacin vs. cefotaxime regimens for the treatment of intra-abdominal infections

1 reference

12 December 2020

Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin

1 reference

12 December 2020

Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly

1 reference

12 December 2020

Activities of newer fluoroquinolones against Shigella sonnei

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of acute pelvic infections in hospitalized women. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Ciprofloxacin for treatment of severe typhoid fever in children

1 reference

12 December 2020

Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens

1 reference

12 December 2020

Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides

1 reference

12 December 2020

A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis

1 reference

12 December 2020

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

In vitro activity of sparfloxacin compared with those of five other quinolones

1 reference

12 December 2020

Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea

1 reference

12 December 2020

Low dose intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD)

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses

1 reference

12 December 2020

Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection

1 reference

12 December 2020

Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections

1 reference

12 December 2020

Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients

1 reference

12 December 2020

Pharmacoeconomic comparison of sequential IV/oral ciprofloxacin versus ceftazidime in the treatment of nosocomial pneumonia

1 reference

12 December 2020

In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent

1 reference

12 December 2020

Effects on growth of single short courses of fluoroquinolones

1 reference

12 December 2020

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

12 December 2020

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

1 reference

12 December 2020

Ciprofloxacin-phenytoin interaction

1 reference

12 December 2020

In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent

1 reference

12 December 2020

Possible interaction between ciprofloxacin and warfarin

1 reference

12 December 2020

Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada

1 reference

12 December 2020

Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers

1 reference

12 December 2020

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of C

1 reference

12 December 2020

Transintestinal elimination of ciprofloxacin

1 reference

12 December 2020

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group

1 reference

12 December 2020

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1 reference

12 December 2020

In vitro activity of fluoroquinolones against gram-positive bacteria

1 reference

12 December 2020

The treatment of gastrointestinal infections with ciprofloxacin

1 reference

12 December 2020

Ciprofloxacin as single-dose antibiotic prophylaxis in colorectal surgery. Results of a randomized, double-blind trial

1 reference

12 December 2020

Individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism in male nonsmokers

1 reference

12 December 2020

Epidemiology of quinolone resistance: Europe and North and South America.

1 reference

12 December 2020

Possible interaction of ciprofloxacin with cyclosporin A

1 reference

12 December 2020

Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin

1 reference

12 December 2020

In-vitro and in-vivo selection of Staphylococcus aureus mutants resistant to ciprofloxacin.

1 reference

12 December 2020

Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg.

1 reference

12 December 2020

In-vitro activity of PD 131628, a new quinolone antimicrobial agent

1 reference

12 December 2020

Sequential antimicrobial therapy: a realistic approach to cost containment?

1 reference

12 December 2020

Efficacy of Ciprofloxacin in the Treatment of Chronic Typhoid Carriers

1 reference

12 December 2020

The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group

1 reference

12 December 2020

A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.

1 reference

12 December 2020

Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.

1 reference

12 December 2020

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

1 reference

12 December 2020

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

12 December 2020

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

1 reference

12 December 2020

[Ciprofloxacin resistance in gram negative bacilli. Epidemiologic aspects]

1 reference

12 December 2020

A comparative study of short course ciprofloxacin treatment in typhoid and paratyphoid fever

1 reference

12 December 2020

Susceptibilities of ampicillin-resistant strains of Salmonella other than S. typhi to 10 antimicrobial agents

1 reference

12 December 2020

A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease

1 reference

12 December 2020

In vitro activities of two glycylcyclines

1 reference

12 December 2020

Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V.

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of acute pelvic inflammatory disease. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study

1 reference

12 December 2020

Increased resistance to quinolone in Catalonia, Spain.

1 reference

12 December 2020

Interaction between ciclosporin and ciprofloxacin

1 reference

12 December 2020

In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin

1 reference

12 December 2020

Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections

1 reference

12 December 2020

Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition

1 reference

12 December 2020

Pharmacoepidemiology of ciprofloxacin: analysis of use patterns and cost impact

1 reference

12 December 2020

Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults.

1 reference

12 December 2020

Open study of ciprofloxacin in enteric fever

1 reference

12 December 2020

Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children

1 reference

12 December 2020

Enteric absorption of ciprofloxacin during the immediate postoperative period

1 reference

12 December 2020

Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline

1 reference

12 December 2020

Lack of increase in resistance to quinolones in general practice isolates of Escherichia coli

1 reference

12 December 2020

Ciprofloxacin for multiresistant enteric fever in pregnancy.

1 reference

12 December 2020

[Ciprofloxacin concentration in human prostatic tissue following 3 days' administration]

1 reference

12 December 2020

DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients

1 reference

12 December 2020

Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial

1 reference

12 December 2020

A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever

1 reference

12 December 2020

The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients

1 reference

12 December 2020

Ciprofloxacin in elderly patients with underlying chronic diseases.

1 reference

12 December 2020

[Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection]

1 reference

12 December 2020

Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition

1 reference

12 December 2020

Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992.

1 reference

12 December 2020

A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.

1 reference

12 December 2020

Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy

1 reference

12 December 2020

Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease

1 reference

12 December 2020

Increasing ciprofloxacin resistance in MRSA.

1 reference

12 December 2020

Use of ciprofloxacin in cystic fibrosis patients

1 reference

12 December 2020

Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii

1 reference

12 December 2020

Travellers' diarrhoea. Which antimicrobial?

1 reference

12 December 2020

Significance of the ciprofloxacin-antacid interaction

1 reference

12 December 2020

Continuing problem of ciprofloxacin administered with interacting drugs

1 reference

12 December 2020

Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis

1 reference

12 December 2020

Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.

1 reference

12 December 2020

An Evaluation of the Quinolone-Theophylline Interaction Using the Food and Drug Administration Spontaneous Reporting System

1 reference

12 December 2020

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

1 reference

12 December 2020

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

12 December 2020

Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adult

1 reference

12 December 2020

A randomised prospective controlled study of ciprofloxacin with metronidazole versus amoxicillin/clavulanic acid with metronidazole in the treatment of intra-abdominal infection

1 reference

12 December 2020

Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance

1 reference

12 December 2020

Effect of ciprofloxacin on the pharmacokinetics of multiple-dose phenytoin serum concentrations

1 reference

12 December 2020

Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents

1 reference

12 December 2020

Treatment of traveler's diarrhea with ciprofloxacin and loperamide

1 reference

12 December 2020

Efficacy and cost-effectiveness of oral ciprofloxacin

1 reference

12 December 2020

In-vitro activity of four new fluoroquinolones.

1 reference

12 December 2020

[Concentrations of new quinolone agents in serum and prostate tissue]

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of cholera. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers

1 reference

12 December 2020

Value of oral antibiotic prophylaxis in colorectal surgery

1 reference

12 December 2020

In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone

1 reference

12 December 2020

Bacteriology of chronic otitis media

1 reference

12 December 2020

Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.

1 reference

12 December 2020

Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials

1 reference

12 December 2020

In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections

1 reference

12 December 2020

Efficacy of ciprofloxacin and norfloxacin in multidrug resistant enteric fever in adults.

1 reference

12 December 2020

Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro

1 reference

12 December 2020

Fluoroquinolones: interaction profile during enteral absorption.

1 reference

12 December 2020

Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones

1 reference

12 December 2020

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents

1 reference

12 December 2020

Emerging resistance to fluoroquinolones in staphylococci: an alert

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of typhoid fever. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.

1 reference

12 December 2020

The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

1 reference

12 December 2020

Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infection

1 reference

12 December 2020

Molecular epidemiology of endemic ciprofloxacin-susceptible and -resistant Enterobacteriaceae.

1 reference

12 December 2020

Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.

1 reference

12 December 2020

Pathogenesis and management of arthropathy in cystic fibrosis

1 reference

12 December 2020

In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.

1 reference

12 December 2020

A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients

1 reference

12 December 2020

Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.

1 reference

12 December 2020

Effect of quinolone antimicrobials on theophylline pharmacokinetics

1 reference

12 December 2020

Ciprofloxacin compared with doxycycline for nongonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection

1 reference

12 December 2020

A follow-up safety study of ciprofloxacin users

1 reference

12 December 2020

Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine

1 reference

12 December 2020

Increasing resistance of enterococci to ciprofloxacin

1 reference

12 December 2020

Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfioxacin, tosufloxacin, CI-960 and CI-990

1 reference

12 December 2020

Interaction between oral ciprofloxacin and caffeine in normal volunteers

1 reference

12 December 2020

Ciprofloxacin: an overview of adverse experiences

1 reference

12 December 2020

Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteria

1 reference

12 December 2020

Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: a randomised double-blind, prospective multicentre study

1 reference

12 December 2020

Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin

1 reference

12 December 2020

Prevention of sepsis following endoscopic retrograde cholangiopancreatography

1 reference

12 December 2020

Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis

1 reference

12 December 2020

Questioning dosing regimens of ciprofloxacin

1 reference

12 December 2020

Study of the efficacy and safety of ciprofloxacin in the treatment of chronic otitis

1 reference

12 December 2020

Sucralfate significantly reduces ciprofloxacin concentrations in serum

1 reference

12 December 2020

Controlled prospective study of oral ciprofloxacin versus amoxycillin/clavulanic acid in chronic suppurative otitis media in adults.

1 reference

12 December 2020

In vitro activity of lomefloxacin as compared with ciprofloxacin

1 reference

12 December 2020

Therapy of acute and chronic Gram-negative osteomyelitis with ciprofloxacin

1 reference

12 December 2020

The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans

1 reference

12 December 2020

Quinolones and Salmonella gastroenteritis

1 reference

12 December 2020

Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin

1 reference

12 December 2020

Clinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients.

1 reference

12 December 2020

Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria

1 reference

12 December 2020

Recommendations for treatment of chancroid, 1993.

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.

1 reference

12 December 2020

Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers

1 reference

12 December 2020

Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients

1 reference

12 December 2020

Ciprofloxacin and warfarin

1 reference

12 December 2020

Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment

1 reference

12 December 2020

Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding

1 reference

12 December 2020

Open, prospective study of the clinical efficacy of ciprofloxacin

1 reference

12 December 2020

The intravitreal penetration of orally administered ciprofloxacin in humans

1 reference

12 December 2020

A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients

1 reference

12 December 2020

In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor

1 reference

12 December 2020

Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India

1 reference

12 December 2020

Short course quinolone therapy of typhoid fever in developing countries.

1 reference

12 December 2020

Effect of the addition of ciprofloxacin on theophylline pharmacokinetics in subjects inhibited by cimetidine

1 reference

12 December 2020

Treatment of Cutaneous Infections Worldwide Experience with Ciprofloxacin

1 reference

12 December 2020

Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin

1 reference

12 December 2020

In vitro evaluation of E-4695, a new fluoro-naphthyridine

1 reference

12 December 2020

The in-vitro activity of RP 59500 against gram-positive cocci

1 reference

12 December 2020

Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994.

1 reference

12 December 2020

[Efficacy of single dose of ciprofloxacin and pefloxacin in the treatment of female acute cystitis].

1 reference

12 December 2020

Interaction between ciprofloxacin and metal cations: its influence on physicochemical characteristics and antibacterial activity.

1 reference

12 December 2020

Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation

1 reference

12 December 2020

In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.

1 reference

12 December 2020

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies

1 reference

12 December 2020

Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever

1 reference

12 December 2020

Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis

1 reference

12 December 2020

A 7-day course of ciprofloxacin for enteric fever

1 reference

12 December 2020

Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Lomefloxacin versus norfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections

1 reference

12 December 2020

Quinolones in chest infections

1 reference

12 December 2020

Overview of fluoroquinolone safety

1 reference

12 December 2020

The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.

1 reference

12 December 2020

The fluoroquinolones as treatment for infections caused by gram-positive bacteria

1 reference

12 December 2020

Intravenous ciprofloxacin versus cefotaxime prophylaxis during transurethral surgery

1 reference

12 December 2020

Single-dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report

1 reference

12 December 2020

Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia

1 reference

12 December 2020

Antibiotic prophylaxis in biliary tract surgery. Ciprofloxacin versus ceftriaxone

1 reference

12 December 2020

Possible phenytoin-ciprofloxacin interaction

1 reference

12 December 2020

Emergence of multidrug-resistant Salmonella typhi in rural southern India

1 reference

12 December 2020

A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections

1 reference

12 December 2020

Safety of intravenous ciprofloxacin. A review

1 reference

12 December 2020

Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa

1 reference

12 December 2020

North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.

1 reference

12 December 2020

Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea.

1 reference

12 December 2020

Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients.

1 reference

12 December 2020

Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin

1 reference

12 December 2020

Patients receiving quinolones and cyclosporine after heart transplantation

1 reference

12 December 2020

Ciprofloxacin drug utilization review and prospective drug use evaluation.

1 reference

12 December 2020

Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics

1 reference

12 December 2020

Penetration of ciprofloxacin into the aqueous humour of the uninflamed human eye after oral administration

1 reference

12 December 2020

Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin

1 reference

12 December 2020

A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily.

1 reference

12 December 2020

Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women

1 reference

12 December 2020

Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections

1 reference

12 December 2020

The selection of appropriate dosages for intravenous ciprofloxacin

1 reference

12 December 2020

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

12 December 2020

In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.

1 reference

12 December 2020

Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial

1 reference

12 December 2020

Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies

1 reference

12 December 2020

In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens

1 reference

12 December 2020

Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia

1 reference

12 December 2020

In vitro studies of ciprofloxacin and survey of resistance patterns in current isolates.

1 reference

12 December 2020

Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients

1 reference

12 December 2020

General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients

1 reference

12 December 2020

Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission.

1 reference

12 December 2020

Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital

1 reference

12 December 2020

Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.

1 reference

12 December 2020

A prospective, double-blind, randomized study comparing the efficacy and safety of low-dose ciprofloxacin with ampicillin in the treatment of bronchitis

1 reference

12 December 2020

Quinolone activity against anaerobes: microbiological aspects.

1 reference

12 December 2020

10.2165/00003495-199651060-00010

Identifiers

DOI

1 reference

Dimensions Publication ID

26 September 2017

1025536074

0 references

1 reference